Skip to main content

Markers and Immunoprofile of Histiocytic and Dendritic Cell Tumors

  • Chapter
  • First Online:
Book cover Immunohistochemistry in Tumor Diagnostics

Abstract

CD1a, CD21, CD23, CD35, CD68, CD207, fascin, podoplanin, and S100 [1, 2]

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dalia S, Jaglal M, Chervenick P. Clinicopathologic characteristics and outcomes of histiocytic and dendritic cell neoplasms: the Moffitt cancer center experience over the last twenty five years. Cancer. 2014;6:2275–95.

    Article  Google Scholar 

  2. Emile JF, Abla O, Fraitag S, et al. Revised classification of histiocytosis and neoplasms of the macrophage-dendritic cell lineage. Blood. 2016;127:2672–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Biddle DA, Ro JY, Yoon GS, et al. Extranodal follicular dendritic cell sarcoma of the head and neck region: three new cases, with a review of the literature. Mod Pathol. 2002;15:50–8.

    Article  PubMed  Google Scholar 

  4. Gaertner EM, Tsokos M, Derringer GA, et al. Interdigitating dendritic cell sarcoma: a report of four cases and review of the literature. Am J Clin Pathol. 2001;115:589–97.

    Article  CAS  PubMed  Google Scholar 

  5. Kairouz S, Hashash J, Kabbara W, et al. Dendritic cell neoplasms: an overview. Am J Hematol. 2007;82:924–8.

    Article  PubMed  Google Scholar 

  6. Xie Q, Chen L, Fu K, et al. Podoplanin (D2-40): a new immunohistochemical marker for reactive follicular dendritic cells and follicular dendritic cell sarcomas. Int J Clin Exp Pathol. 2008;1:276–84.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Heim-Hall J, Yohe L. Application of immunohistochemistry to soft tissue neoplasms. Arch Pathol Lab Med. 2008;132:476–89.

    PubMed  Google Scholar 

  8. Fabriek BO, Dijkstra CD, van den Berg TK. The macrophage scavenger receptor CD163. Immunobiology. 2005;210(2-4):153–60.

    Article  CAS  PubMed  Google Scholar 

  9. Akila P, Prashant V, Suma MN, et al. CD163 and its expanding functional repertoire. Clin Chem Acta. 2012;11(7–8):669–74.

    Article  Google Scholar 

  10. Allen CE, Li L, Peters TL, et al. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared to epidermal Langerhans cells. J Immunol. 2010;184(8):4557–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Tuffaha, M.S.A., Guski, H., Kristiansen, G. (2018). Markers and Immunoprofile of Histiocytic and Dendritic Cell Tumors. In: Immunohistochemistry in Tumor Diagnostics. Springer, Cham. https://doi.org/10.1007/978-3-319-53577-7_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-53577-7_19

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-53576-0

  • Online ISBN: 978-3-319-53577-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics